1. Home
  2. Medical News
  3. Cornea

New Study Highlights Tiny Vesicles With Big Potential for Corneal Disease Treatment

12/17/2025

In a comprehensive new review published in the journal Cells, scientists are spotlighting exosomes—minute communication vesicles released by cells—as promising tools for diagnosing and treating diseases of the cornea.

Exosomes are nano-sized, membrane-bound particles (50–150 nm in diameter) that shuttle biological materials such as proteins, lipids, RNA, and DNA between cells. Researchers say these tiny 'messengers' play a key role in how cells communicate and respond to stress, injury, and disease.

The review, authored by a team at Cedars-Sinai Medical Center and the University of California, Los Angeles, outlines how exosomes influence important processes in the eye—including wound healing, scarring, and inflammation. Because exosomes naturally circulate in bodily fluids like tears and blood and are relatively stable and non-immunogenic, the authors argue they could be harnessed as both biomarkers and therapeutic delivery vehicles.  

“Exosomes have unique advantages: they reflect the molecular state of their cells of origin and can travel to distant sites, delivering tailored molecular cargo to recipient cells,” according to the study. The authos say engineered exosomes could one day deliver drugs or genetic material to treat corneal damage. 

Corneal diseases—ranging from trauma and infections to degenerative conditions—remain a major cause of visual impairment worldwide. Traditional treatments often focus on symptom management or surgical intervention, but the latest research indicates that exosome-based approaches might enable more precise and less invasive therapies.  

The authors note that hurdles remain before exosome-based therapies reach the clinic. Scientists must better understand how to control and standardize exosome production, delivery, and targeting.

Reference

Gamez, J., Zha, D., Ebrahimi, S. M., White, S., Ljubimov, A. V., & Saghizadeh, M. (2025). Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases. Cells, 14(13), 959. https://doi.org/10.3390/cells14130959

Register

We're glad to see you're enjoying Cataract & Refractive Surgery Today Global…
but how about a more personalized experience?

Register for free